Schedule 13G ownership disclosure

Terns Pharmaceuticals Inc

Security class unavailable · CUSIP: 880881107

Event date: 2022-12-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-22-083501
Form type
SC 13G/A
Filer
LAV Biosciences Fund V, L.P.
CIK
CIK 1764435
Filed
Dec 29, 2022
Reporting period
Dec 27, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub